Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets

被引：0
作者：
Daniel Aletaha
Josef S. Smolen
机构：
[1] Medical University of Vienna,Division of Rheumatology, Department of Medicine 3
来源：
Nature Reviews Rheumatology | 2019年 / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
For too long, the definition of ‘remission’ in rheumatoid arthritis has been distorted by the widespread use of an inadequate tool, with consequences for clinical care and for making sense of clinical trial data. Has the time come to move away from DAS28-defined remission?
引用
收藏
页码：633 / 634
页数：1
相关论文
共 50 条
  • [21] Association of Comorbidities with DAS28 Disease Status and Remission in Race/Ethnic Groups with Rheumatoid Arthritis
    Dowell, Sharon
    Perez-Alamino, Rodolfo
    Swearingen, Christopher J.
    Kerr, Gail S.
    Yazici, Yusuf
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [22] COMPARISON OF DAS28 USING ESR AND CRP IN AN EARLY RHEUMATOID ARTHRITIS COHORT
    Bykerk, V. P.
    Pope, J. E.
    Xiong, J.
    Boire, G.
    Haraoui, B.
    Thorne, J. C.
    Hitchon, C. A.
    Tin, D.
    Keystone, E. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 590 - 591
  • [23] CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice
    Takanashi, Satoshi
    Kaneko, Yuko
    Takeuchi, Tsutomu
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (05) : 671 - +
  • [24] Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis
    Thiele, Katja
    Huscher, Doerte
    Bischoff, Sascha
    Spaethling-Mestekemper, Susanna
    Backhaus, Marina
    Aringer, Martin
    Kohlmann, Thomas
    Zink, Angela
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (07) : 1194 - 1199
  • [25] Effects of Tocilizumab on DAS28 in Patients with Rheumatoid Arthritis (RA)
    Gibiansky, Leonid
    Frey, Nicolas
    Hsu, Joy C.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S84 - S85
  • [26] CDAI AND DAS28 IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE
    Takanashi, S.
    Kaneko, Y.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 976 - 976
  • [27] DISCREPANCIES IN CATEGORISING EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS PATIENTS BY DAS28(ESR) AND DAS28(CRP): CAN THEY BE REDUCED?
    Hensor, Elizabeth M.
    Emery, Paul
    Bingham, Sarah J.
    Conaghan, Philip G.
    Consortium, Year
    RHEUMATOLOGY, 2009, 48 : I137 - I137
  • [28] Look Beyond the Disease Activity Score of 28 Joints (DAS28): Tender Points Influence the DAS28 in Patients with Rheumatoid Arthritis
    Ton, Evelien
    Bakker, Marije F.
    Verstappen, Suzanne M. M.
    ter Borg, Evert Jan
    van Albada-Kuipers, Iet A.
    Schenk, Yolande
    van der Veen, Maaike J.
    Bijlsma, Johannes W. J.
    Jacobs, Johannes W. G.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (01) : 22 - 27
  • [29] RELATIONSHIP BETWEEN DAS28 CATEGORIES AND RHEUMATOID ARTHRITIS IMPACT OF DISEASE (RAID) PATIENT REPORTED OUTCOME IN RHEUMATOID ARTHRITIS: SIGNIFICANT ADVANTAGE OF TARGETING DAS REMISSION
    Smith, Catherine
    Prideaux, Amy A.
    Kiely, Patrick D. W.
    RHEUMATOLOGY, 2018, 57
  • [30] REMAINING FOOT SYNOVITIS MAY PREDICT RELAPSE IN RHEUMATOID ARTHRITIS PATIENTS IN DAS28 REMISSION (DAS28-CRP<2.3)
    Hattori, S.
    Hagino, N.
    Yomono, K.
    Tsuzuki, S.
    Suzuki, S.
    Takenouchi, S.
    Yokochi, R.
    Matsui, T.
    Tohma, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1330 - 1330
12345